Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 2004, p. 1803-1806, Vol. 48, No. 5
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.5.1803-1806.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening
Martin Smilkstein,1,2* Nongluk Sriwilaijaroen,3 Jane Xu Kelly,1 Prapon Wilairat,3 and Michael Riscoe1,2
Medical Research Service, Department of Veterans Affairs Medical Center,1
Oregon Health and Science University, Portland, Oregon,2
Department of Biochemistry, Mahidol University, Bangkok, Thailand3
Received 15 August 2003/
Returned for modification 27 October 2003/
Accepted 12 January 2004
Radioisotopic assays involve expense, multistep protocols, equipment, and radioactivity safety requirements which are problematic in high-throughput drug testing. This study reports an alternative, simple, robust, inexpensive, one-step fluorescence assay for use in antimalarial drug screening. Parasite growth is determined by using SYBR Green I, a dye with marked fluorescence enhancement upon contact with Plasmodium DNA. A side-by-side comparison of this fluorescence assay and a standard radioisotopic method was performed by testing known antimalarial agents against Plasmodium falciparum strain D6. Both assay methods were used to determine the effective concentration of drug that resulted in a 50% reduction in the observed counts (EC50) after 48 h of parasite growth in the presence of each drug. The EC50s of chloroquine, quinine, mefloquine, artemisinin, and 3,6-bis-
-(N,N-diethylamino)-amyloxyxanthone were similar or identical by both techniques. The results obtained with this new fluorescence assay suggest that it may be an ideal method for high-throughput antimalarial drug screening.
* Corresponding author. Mailing address: Medical Research Service, Department of Veterans Affairs Medical Center, RD-33, 3710 SW US Veterans Hospital Rd., Portland, OR 97201. Phone: (503) 220-8262, ext. 54131. Fax: (503) 721-1084. E-mail: smilkste{at}earthlink.net.
Antimicrobial Agents and Chemotherapy, May 2004, p. 1803-1806, Vol. 48, No. 5
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.5.1803-1806.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Liu, S., Mu, J., Jiang, H., Su, X.-z.
(2008). Effects of Plasmodium falciparum Mixed Infections on In Vitro Antimalarial Drug Tests and Genotyping. Am J Trop Med Hyg
79: 178-184
[Abstract]
[Full Text]
-
Plouffe, D., Brinker, A., McNamara, C., Henson, K., Kato, N., Kuhen, K., Nagle, A., Adrian, F., Matzen, J. T., Anderson, P., Nam, T.-g., Gray, N. S., Chatterjee, A., Janes, J., Yan, S. F., Trager, R., Caldwell, J. S., Schultz, P. G., Zhou, Y., Winzeler, E. A.
(2008). From the Cover: In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc. Natl. Acad. Sci. USA
105: 9059-9064
[Abstract]
[Full Text]
-
Kelly, J. X., Smilkstein, M. J., Cooper, R. A., Lane, K. D., Johnson, R. A., Janowsky, A., Dodean, R. A., Hinrichs, D. J., Winter, R., Riscoe, M.
(2007). Design, Synthesis, and Evaluation of 10-N-Substituted Acridones as Novel Chemosensitizers in Plasmodium falciparum. Antimicrob. Agents Chemother.
51: 4133-4140
[Abstract]
[Full Text]
-
Johnson, J. D., Dennull, R. A., Gerena, L., Lopez-Sanchez, M., Roncal, N. E., Waters, N. C.
(2007). Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening. Antimicrob. Agents Chemother.
51: 1926-1933
[Abstract]
[Full Text]
-
Bacon, D. J., Latour, C., Lucas, C., Colina, O., Ringwald, P., Picot, S.
(2007). Comparison of a SYBR Green I-Based Assay with a Histidine-Rich Protein II Enzyme-Linked Immunosorbent Assay for In Vitro Antimalarial Drug Efficacy Testing and Application to Clinical Isolates. Antimicrob. Agents Chemother.
51: 1172-1178
[Abstract]
[Full Text]
-
Baniecki, M. L., Wirth, D. F., Clardy, J.
(2007). High-Throughput Plasmodium falciparum Growth Assay for Malaria Drug Discovery. Antimicrob. Agents Chemother.
51: 716-723
[Abstract]
[Full Text]
-
Kaddouri, H., Nakache, S., Houze, S., Mentre, F., Le Bras, J.
(2006). Assessment of the Drug Susceptibility of Plasmodium falciparum Clinical Isolates from Africa by Using a Plasmodium Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory Concentration.. Antimicrob. Agents Chemother.
50: 3343-3349
[Abstract]
[Full Text]
-
Persson, K. E. M., Lee, C. T., Marsh, K., Beeson, J. G.
(2006). Development and Optimization of High-Throughput Methods To Measure Plasmodium falciparum-Specific Growth Inhibitory Antibodies.. J. Clin. Microbiol.
44: 1665-1673
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.